The Concept of Endocannabinoid Signaling System in Cancer: An Emerging Target of Pharmacotherapy - Softcover

Fatima, Talath; Azeez, Syed Abdul

Softcover

ISBN 10: 3330026499 ISBN 13: 9783330026490

Publisher: LAP LAMBERT Academic Publishing, 2016

Synopsis

Endogenous arachidonic acid metabolites with properties similar to compounds of Cannabis sativa Linnaeus, the so-called Endocannabinoids, have effects on various types of cancer. The main active ingredient of cannabis, Δ9-tetrahydrocannabinol (Δ9-THC), produces its effects through activation of CB1 and CB2 receptors. CB1 receptors are expressed at high levels in the central nervous system (CNS), whereas CB2 receptors are concentrated predominantly, although not exclusively, in cells of the immune system. Although endocannabinoids and synthetic cannabinoids may have pro-proliferative effects, predominantly inhibitory effects on tumor growth, angiogenesis, migration and metastasis have been described. Exceptionally, these effects may be selective for the cancer cells, while normal cells and tissues are spared. Such apparent tumor cell selectivity makes the endocannabinoid system an attractive potential target for cancer therapy. Further basic research on anti-cancer properties of cannabinoids as well as clinical trials of cannabinoid therapeutic efficacy in breast, prostate and bone cancer is therefore warranted.

About this title

About the Author

Talath Fatima is a Pharmacy Student at Deccan School of Pharmacy, Hyderabad. She has 15 Scientific Publications to her Credit.She serves as one of the youngest Editorial Board Members of three Pharmaceutical Journals.Dr.Syed Abdul Azeez is Academician, Scientist & Administrator served in Public/Private Organisations having 60 publications to credit

Edition details

• Publisher: LAP LAMBERT Academic Publishing
• Publication date: 2016
• Language: English
• ISBN 10: 3330026499
• ISBN 13: 9783330026490
• Binding: Paperback
• Number of pages: 80